The boston keratoprosthesis

International Ophthalmology Clinics

Volumn 50, Issue 3, 2010, Pages 161-175

  Klufas, Michael A ^a   Colby, Kathryn A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; BRIMONIDINE; GATIFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANIRIDIA; ANTIBIOTIC PROPHYLAXIS; CONTACT LENS; DRUG WITHDRAWAL; ENDOPHTHALMITIS; GLAUCOMA; HERPES SIMPLEX KERATITIS; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; KERATOPROSTHESIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; UNITED STATES; CORNEA TRANSPLANTATION; CORNEAL DISEASES; DEVICES; PROSTHESES AND ORTHOSES; PROSTHESIS; TREATMENT OUTCOME;

CORNEAL DISEASES; CORNEAL TRANSPLANTATION; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 77954645266     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181e20cca     Document Type: Review

References (44)

1. Cornea Donation & Transplantation Statistics. http://www. restoresight.org/donation/ statistics.htm. Accessed August 5, 2009.
2. Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin Fall. 2005;45:49-59.
3. Aquavella JV, Gearinger MD, Akpek EK, et al. Pediatric keratoprosthesis. Ophthalmology. 2007;114:989-994.
4. Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye. 2009;10: 1966-1971.
5. Harissi-Dagher M, Dohlman CH. The Boston keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008;43:165-169.
6. Chirila TV, Hicks CR. The origins of the artificial cornea: pellier de quengsy and his contribution to the modern concept of keratoprosthesis. Gesnerus. 1999;56:96-106.
7. Pellier de Quengsy G. Précis au cours d'operations sur la chirurgie des yeux. Paris: Didot; 1789.
8. Liu C, Paul B, Tandon R, et al. The osteo-odonto-keratoprosthesis (OOKP). Semin Ophthalmol. 2005;20:113-128.
9. Ciolino JB, Dohlman CH. Biologic keratoprosthesis materials. Int Ophthalmol Clin Winter. 2009;49:1-9.
10. Ament JD, Stryjewski TP, Ciolino JB, et al. Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol. 2010;149:221-228.
11. Dohlman C, Harissi-Dagher M. The Boston keratoprosthesis: a new threadless design. Digital J Opthalmol. 2007;13(3).
12. Khan B, Dudenhoefer EJ, Dohlman CH. Keratoprosthesis: an update. Curr Opin Ophthalmol. 2001;12:282-287.
13. Todani A, Gupta P, Colby K. Type I Boston keratoprosthesis with cataract extraction and intraocular lens placement for visual rehabilitation of herpes zoster ophthalmicus: the ''KPro Triple''. Br J Ophthalmol. 2009;93:119.
14. Harissi-Dagher M, Colby KA. Cataract extraction after implantation of a type I Boston keratoprosthesis. Cornea. 2008;27:220-222.
15. Khan BF, Harissi-Dagher M, Khan DM, et al. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin Spring. 2007;47:61-71.
16. Harissi-Dagher M, Khan BF, Schaumberg DA, et al. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26: 564-568.
17. Ament JD, Spurr-Michaud SJ, Dohlman CH, et al. The Boston keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea. 2009;28:808-811.
18. Dohlman CH, Colby KA, Belin MW, et al. Titanium versus PMMA backplates for Boston keratoprosthesis: incidence of retroprosthetic membrane. Invest Ophthalmol. Vis. Sci. 2009;50: (E-Abstract 1505).
19. Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin Spring. 2008;48:43-51.
20. Dohlman CH, Dudenhoefer EJ, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. Clao J. 2002;28:72-74.
21. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484-489.
22. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28:896-901.
23. McLellan C, Ngo V, Pasedis S, et al. Testing the long-term stability of vancomycin ophthalmic solution. International J Pharmaceutical Compounding. 2008;12:456-459.
24. Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci. 2009;50:3346-3352.
25. Ciolino JB, Dohlman CH, Kohane DS. Contact lenses for drug delivery. Semin Ophthalmol. 2009;24:156-160.
26. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19-23.
27. Sayegh RR, Ang LP, Foster CS, et al. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145:438-444.
28. Khan BF, Harissi-Dagher M, Pavan-Langston D, et al. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol. 2007;125:745-749.
29. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol. 2007;144:227-231.
30. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116:640-651.
31. Hicks CR, Crawford GJ, Tan DT, et al. Outcomes of implantation of an artificial cornea, AlphaCor: effects of prior ocular herpes simplex infection. Cornea. 2002;21: 685-690.
32. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the university of California Davis experience. Cornea. 2009;28:321-327.
33. Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology. 2006;113:e1771-e1777, 1779.
34. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28:989-996.
35. Ciolino JB, Ament JW, Zerbe BL, et al. Etiology of keratoprosthesis loss: results from the Boston keratoprosthesis multicenter study. Invest Ophthalmol Vis Sci. 2008;49: (E-Abstract 5712).
36. Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24:915-919.
37. Ray S, Khan BF, Dohlman CH, et al. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120:559-566.
38. Dohlman CH, Harissi-Dagher M, Khan BF, et al. Introduction to the use of the Boston keratoprosthesis. Expert Rev Ophthalmol. 2006;1:41-48.
39. Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology. 1998;105:751-757.
40. Todani A, Fava MA, Melki SA, et al. Measurement of IOP with intraocular pressure transducer. Invest. Ophthalmol. Vis. Sci. 2009;50: (E-Abstract 5220).
41. Rivier D, Paula JS, Kim E, et al. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009;18:321-324.
42. Dohlman CH, Grosskreutz CL, Chen TC, et al. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma. 2010;19: 111-115.
43. Rubin PA, Chang E, Bernardino CR, et al. Oculoplastic technique of connecting a glaucoma valve shunt to extraorbital locations in cases of severe glaucoma. Ophthal Plast Reconstr Surg. 2004;20:362-367.
44. Fintelmann RE, Maguire JI, Ho AC, et al. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea. 2009;28:877-878.